» Articles » PMID: 16962916

Screening for Thrombophilia

Overview
Date 2006 Sep 12
PMID 16962916
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Thrombophilia screening may be useful in patients at high risk of VTE because it may improve clinical outcome. Family screening allows primary prophylaxis for high-risk situations and counseling of women considering hormonal therapy and pregnancy. Until we find useful and inexpensive screening tools, it is not recommended to test every patient or her/his relatives. Each index case should be carefully evaluated by an expert physician who should tailor the laboratory testing and treatment modalities.

Citing Articles

Diagnosis and Challenges in Perinatal Health.

Riquelme-Gallego B, Caparros-Gonzalez R Diagnostics (Basel). 2022; 12(6).

PMID: 35741210 PMC: 9221575. DOI: 10.3390/diagnostics12061399.


Testing for hereditary thrombophilia: a retrospective analysis of testing referred to a national laboratory.

Jackson B, Holmes K, Phansalkar A, Rodgers G BMC Clin Pathol. 2008; 8:3.

PMID: 18384680 PMC: 2324095. DOI: 10.1186/1472-6890-8-3.